Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 5Sarcoma 4Gastrointestinal 4CNS 4Gynecologic 3Genitourinary 3Classical hematology 3Tumor-Agnostic 2Head & Neck 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Head and Neck Neoplasms 2

Interventions

Cisplatin 619pembrolizumab 323Radiotherapy 319Cetuximab 274Docetaxel 220Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 74Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 48Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 43tislelizumab 42Standard of Care 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Tranexamic Acid × Head & Neck × Clear all
NCT00147862 2007-02-07

Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?

Tata Memorial Hospital

Phase 3 Completed
240 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00308880 2006-03-30

Tranexamic Acid and Head and Neck Surgery Patients

Taichung Veterans General Hospital

Phase 3 Unknown
80 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡